Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.

Source:http://linkedlifedata.com/resource/pubmed/id/3120854

Br Med J (Clin Res Ed) 1987 Oct 24 295 6605 1017-20

Download in:

View as

General Info

PMID
3120854